• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身免疫炎症指数可能预测神经母细胞瘤的死亡率。

Systemic Immune-Inflammation Index May Predict Mortality in Neuroblastoma.

作者信息

Cesur Ilknur Banlı, Özçelik Zerrin

机构信息

Pediatric Surgery, Adana City Training Hospital, Adana, TUR.

出版信息

Cureus. 2023 Mar 2;15(3):e35705. doi: 10.7759/cureus.35705. eCollection 2023 Mar.

DOI:10.7759/cureus.35705
PMID:36875247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9982472/
Abstract

INTRODUCTION

Neuroblastomas (NB) are among the most frequent childhood solid tumors. The link between inflammation and cancer is well understood. Many research studies have been conducted to determine the prognostic importance of inflammatory markers in cancer patients. C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) are all potential inflammation indicators. The purpose of this study is to assess the efficacy of NLR and SII as inflammatory indicators in predicting NB patient survival.

MATERIALS AND METHODS

Patients with NB diagnosed between January 1, 2012 and December 31, 2021 were studied retrospectively, and death was documented. By dividing the number of neutrophils by the number of lymphocytes, the NLR was obtained. The SII was calculated by multiplying the NLR by the platelet count.

RESULTS

46 patients with NB were included in the study with a mean age of 57.58 months (4.14-170.05). When the patients were analyzed based on mortality the NLR and SII values were statistically significantly increased in the dead group (2.71 (1.22-4.1 ) vs. 1.7 (0.16-5.1); p=0.02; and 677.8 (215-1322) vs. 294.6 (69.49-799.1), respectively; p=0.012). Analysis of the receiver operating curve found that 328.49 is the ideal cutoff value for SII to predict mortality with a sensitivity of 83% and a specificity of 68% (area under the receiver operating characteristic curve = 0.814 (95% confidence interval: 0.671-0.956), p=0.005 ). Analyzing the influence of risk factors on survival using Cox regression analysis, SII was discovered as a significant predictor of survival in the study (HR =1.001, 95% CI =1-1.20; p=0.049).

CONCLUSION

SII may be used to predict the overall survival of NB patients.

摘要

引言

神经母细胞瘤(NB)是儿童期最常见的实体瘤之一。炎症与癌症之间的联系已为人熟知。已经开展了许多研究以确定炎症标志物在癌症患者中的预后重要性。C反应蛋白(CRP)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)以及全身免疫炎症指数(SII)都是潜在的炎症指标。本研究的目的是评估NLR和SII作为炎症指标在预测NB患者生存方面的有效性。

材料与方法

对2012年1月1日至2021年12月31日期间确诊的NB患者进行回顾性研究,并记录死亡情况。通过将中性粒细胞数量除以淋巴细胞数量得出NLR。SII通过将NLR乘以血小板计数来计算。

结果

46例NB患者纳入研究,平均年龄57.58个月(4.14 - 170.05)。根据死亡率对患者进行分析时,死亡组的NLR和SII值在统计学上显著升高(分别为2.71(1.22 - 4.1)对1.7(0.16 - 5.1);p = 0.02;以及677.8(215 - 1322)对294.6(69.49 - 799.1),p = 0.012)。对受试者工作曲线进行分析发现,328.49是SII预测死亡率的理想临界值,敏感性为83%,特异性为68%(受试者工作特征曲线下面积 = 0.814(95%置信区间:0.671 - 0.956),p = 0.005)。使用Cox回归分析危险因素对生存的影响时,发现SII是该研究中生存的显著预测因素(HR = 1.001,95% CI = 1 - 1.20;p = 0.049)。

结论

SII可用于预测NB患者的总生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa9/9982472/d149e8d34534/cureus-0015-00000035705-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa9/9982472/d149e8d34534/cureus-0015-00000035705-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa9/9982472/d149e8d34534/cureus-0015-00000035705-i01.jpg

相似文献

1
Systemic Immune-Inflammation Index May Predict Mortality in Neuroblastoma.全身免疫炎症指数可能预测神经母细胞瘤的死亡率。
Cureus. 2023 Mar 2;15(3):e35705. doi: 10.7759/cureus.35705. eCollection 2023 Mar.
2
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.系统免疫炎症指数、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值可预测纳武利尤单抗治疗转移性非小细胞肺癌患者的临床结局。
J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8.
3
The prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index on short- and long-term outcome following surgery for spinal metastases.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和全身免疫炎症指数对脊柱转移瘤手术后短期和长期预后的预测作用。
J Neurosurg Spine. 2023 Dec 29;40(4):475-484. doi: 10.3171/2023.10.SPINE23851. Print 2024 Apr 1.
4
[Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].[直肠癌患者术前炎症指标与预后的关系及预后列线图预测模型的建立]
Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):402-409. doi: 10.3760/cma.j.cn112152-20200630-00612.
5
The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study.全身免疫炎症指数和中性粒细胞与淋巴细胞比值在预测睾丸生殖细胞肿瘤中的价值:一项回顾性临床研究
Front Oncol. 2022 Sep 16;12:893877. doi: 10.3389/fonc.2022.893877. eCollection 2022.
6
[The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].[术前外周血炎症生物标志物对肝内胆管癌根治性切除术后的预后价值]
Zhonghua Zhong Liu Za Zhi. 2022 Nov 23;44(11):1194-1201. doi: 10.3760/cma.j.cn112152-20210324-00265.
7
Single and combined use of the platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and systemic immune-inflammation index in gastric cancer diagnosis.血小板-淋巴细胞比值、中性粒细胞-淋巴细胞比值及全身免疫炎症指数在胃癌诊断中的单独及联合应用
Front Oncol. 2023 Mar 30;13:1143154. doi: 10.3389/fonc.2023.1143154. eCollection 2023.
8
Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection?入院时的全身免疫炎症指数能否预测 SARS-CoV-2 感染的慢性肾脏病患者的住院死亡率?
Nefrologia (Engl Ed). 2022 Sep-Oct;42(5):549-558. doi: 10.1016/j.nefroe.2021.09.009.
9
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio levels are associated with keratoconus.全身免疫炎症指数、中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值水平与圆锥角膜有关。
Indian J Ophthalmol. 2021 Jul;69(7):1725-1729. doi: 10.4103/ijo.IJO_3011_20.
10
Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection?入院时的全身免疫炎症指数能否预测感染SARS-CoV-2的慢性肾脏病患者的院内死亡率?
Nefrologia. 2022 Sep-Oct;42(5):549-558. doi: 10.1016/j.nefro.2021.09.001. Epub 2021 Sep 15.

引用本文的文献

1
A nomogram for predicting early bacterial infection after liver transplantation: a retrospective study.预测肝移植术后早期细菌感染的列线图:一项回顾性研究
Front Med (Lausanne). 2025 Apr 10;12:1563235. doi: 10.3389/fmed.2025.1563235. eCollection 2025.
2
Exploring the role of neutrophil extracellular traps in neuroblastoma: identification of molecular subtypes and prognostic implications.探索中性粒细胞胞外诱捕网在神经母细胞瘤中的作用:分子亚型的鉴定及预后意义
Front Oncol. 2024 Nov 7;14:1361871. doi: 10.3389/fonc.2024.1361871. eCollection 2024.
3
Immunomodulatory properties of extracellular vesicles isolated from bone marrow of patients with neuroblastoma: role of PD-L1 and HLA-G.

本文引用的文献

1
Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.胃食管结合部腺癌患者全身炎症反应指数的预后价值:倾向评分匹配分析。
Dis Markers. 2019 Nov 4;2019:4659048. doi: 10.1155/2019/4659048. eCollection 2019.
2
The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.C-反应蛋白作为软组织肉瘤患者疾病特异性生存的独立预后指标的价值:一项荟萃分析。
PLoS One. 2019 Jul 1;14(7):e0219215. doi: 10.1371/journal.pone.0219215. eCollection 2019.
3
从神经母细胞瘤患者骨髓中分离的细胞外囊泡的免疫调节特性:PD-L1 和 HLA-G 的作用。
Front Immunol. 2024 Oct 24;15:1469771. doi: 10.3389/fimmu.2024.1469771. eCollection 2024.
4
Prognostic role of the controlling nutritional status (CONUT) score in patients with biliary tract cancer: a meta-analysis.控制营养状态(CONUT)评分对胆道癌患者预后的作用:一项荟萃分析。
Ann Med. 2023;55(2):2261461. doi: 10.1080/07853890.2023.2261461. Epub 2023 Sep 26.
5
Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.全身免疫炎症指数在卵巢癌患者中的预后意义:一项荟萃分析。
Front Oncol. 2023 Jun 5;13:1193962. doi: 10.3389/fonc.2023.1193962. eCollection 2023.
The Role of Platelets in the Tumor-Microenvironment and the Drug Resistance of Cancer Cells.
血小板在肿瘤微环境及癌细胞耐药性中的作用
Cancers (Basel). 2019 Feb 19;11(2):240. doi: 10.3390/cancers11020240.
4
Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.血小板与淋巴细胞比值作为新辅助化疗治疗乳腺癌完全病理缓解的预测因子。
PLoS One. 2018 Nov 14;13(11):e0207224. doi: 10.1371/journal.pone.0207224. eCollection 2018.
5
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis.癌症中全身免疫炎症指数的预后价值:一项荟萃分析。
J Cancer. 2018 Sep 7;9(18):3295-3302. doi: 10.7150/jca.25691. eCollection 2018.
6
Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer.术前全身性免疫炎症指数升高可预测可手术非小细胞肺癌患者的预后不良。
Clin Chim Acta. 2018 Sep;484:272-277. doi: 10.1016/j.cca.2018.05.059. Epub 2018 May 31.
7
Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.全身免疫炎症指数(SII)有助于预测符合杭州标准的肝细胞癌肝移植患者的生存结局。
Cell Physiol Biochem. 2018;47(1):293-301. doi: 10.1159/000489807. Epub 2018 May 11.
8
Systemic Immune-inflammation Index Predicts Survival of Patients After Curative Resection for Non-small Cell Lung Cancer.全身免疫炎症指数可预测非小细胞肺癌根治性切除术后患者的生存率。
In Vivo. 2018 May-Jun;32(3):663-667. doi: 10.21873/invivo.11291.
9
Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和 C 反应蛋白作为新型简单预后因素在接受酪氨酸激酶抑制剂治疗的转移性肾细胞癌患者中的应用:系统评价和荟萃分析。
Clin Genitourin Cancer. 2018 Jun;16(3):e685-e693. doi: 10.1016/j.clgc.2018.01.010. Epub 2018 Feb 2.
10
Systemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.全身免疫炎症指数作为一种有用的预后指标可预测接受新辅助化疗的晚期胃癌患者的生存情况。
Cancer Manag Res. 2017 Dec 14;9:849-867. doi: 10.2147/CMAR.S151026. eCollection 2017.